Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 412

1.

Modifying the soil to affect the seed: role of stromal-derived matrix metalloproteinases in cancer progression.

Jodele S, Blavier L, Yoon JM, DeClerck YA.

Cancer Metastasis Rev. 2006 Mar;25(1):35-43. Review.

PMID:
16680570
2.

Critical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatment.

Zucker S, Cao J, Chen WT.

Oncogene. 2000 Dec 27;19(56):6642-50. Review.

3.

Matrix-degrading metalloproteinases in tumor progression.

Matrisian LM, Wright J, Newell K, Witty JP.

Princess Takamatsu Symp. 1994;24:152-61. Review.

PMID:
8983072
4.

Tumor and stromal expression of matrix metalloproteinases and their role in tumor progression.

Crawford HC, Matrisian LM.

Invasion Metastasis. 1994-1995;14(1-6):234-45. Review.

PMID:
7657516
5.

Role of matrix metalloproteinases in melanoma cell invasion.

Hofmann UB, Houben R, Bröcker EB, Becker JC.

Biochimie. 2005 Mar-Apr;87(3-4):307-14. Review.

PMID:
15781317
6.

Matrix metalloproteinases in tumor progression: focus on basal and squamous cell skin cancer.

Kerkelä E, Saarialho-Kere U.

Exp Dermatol. 2003 Apr;12(2):109-25. Review.

PMID:
12702139
7.

Tumor-stroma interactions directing phenotype and progression of epithelial skin tumor cells.

Mueller MM, Fusenig NE.

Differentiation. 2002 Dec;70(9-10):486-97. Review.

PMID:
12492491
8.

Matrix metalloproteinases in tumor-host cell communication.

Lynch CC, Matrisian LM.

Differentiation. 2002 Dec;70(9-10):561-73. Review.

PMID:
12492497
9.

Matrix metalloproteinases and tumor metastasis.

Deryugina EI, Quigley JP.

Cancer Metastasis Rev. 2006 Mar;25(1):9-34. Review.

PMID:
16680569
10.

Tumour invasion and matrix metalloproteinases.

Polette M, Nawrocki-Raby B, Gilles C, Clavel C, Birembaut P.

Crit Rev Oncol Hematol. 2004 Mar;49(3):179-86. Review.

PMID:
15036258
11.

Matrix metalloproteinases: multifunctional contributors to tumor progression.

McCawley LJ, Matrisian LM.

Mol Med Today. 2000 Apr;6(4):149-56. Review.

PMID:
10740253
12.

MT1-MMP: universal or particular player in angiogenesis?

Genís L, Gálvez BG, Gonzalo P, Arroyo AG.

Cancer Metastasis Rev. 2006 Mar;25(1):77-86. Review.

PMID:
16680574
13.

Stromal cells as the major source for matrix metalloproteinase-2 in cutaneous melanoma.

Hofmann UB, Eggert AA, Blass K, Bröcker EB, Becker JC.

Arch Dermatol Res. 2005 Oct;297(4):154-60. Epub 2005 Oct 26.

PMID:
16047212
14.

[Roles of serine proteases and matrix metalloproteinases in tumor invasion and angiogenesis].

Masson V.

Bull Mem Acad R Med Belg. 2006;161(5):320-6. French.

PMID:
17283905
15.

Roles of matrix metalloproteinases in tumor metastasis and angiogenesis.

Yoon SO, Park SJ, Yun CH, Chung AS.

J Biochem Mol Biol. 2003 Jan 31;36(1):128-37. Review.

PMID:
12542983
16.

Matrix metalloproteinases in cancer: from new functions to improved inhibition strategies.

Folgueras AR, Pendás AM, Sánchez LM, López-Otín C.

Int J Dev Biol. 2004;48(5-6):411-24. Review.

17.

EMMPRIN/CD147, an MMP modulator in cancer, development and tissue repair.

Gabison EE, Hoang-Xuan T, Mauviel A, Menashi S.

Biochimie. 2005 Mar-Apr;87(3-4):361-8. Review.

PMID:
15781323
18.

[Tumor-stroma interactions].

Billottet C, Jouanneau J.

Bull Cancer. 2008 Jan;95(1):51-6. doi: 10.1684/bdc.2008.0560. Review. French.

20.

Pericellular proteases in angiogenesis and vasculogenesis.

van Hinsbergh VW, Engelse MA, Quax PH.

Arterioscler Thromb Vasc Biol. 2006 Apr;26(4):716-28. Epub 2006 Feb 9. Review.

Supplemental Content

Support Center